1972
DOI: 10.1007/bf01225575
|View full text |Cite
|
Sign up to set email alerts
|

Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers

Abstract: Summary. Human neonates have been studied during the first hours of life. Blood glucose, portal plasma insulin and glucagon have been determined both at regular intervals up to 24 h after birth and during an intravenous glucose load performed at the 24th h. A material presenting the immunological characteristics of pancreatic glucagon has been found in the portal plasma of both normal infants and infants from diabetic mothers (IDM). The intravenous glucose load did not suppress plasma glucagon in the normal ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
11
1

Year Published

1973
1973
1986
1986

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(15 citation statements)
references
References 11 publications
3
11
1
Order By: Relevance
“…Edwards et al (4) have reported that during the first 3 days of life the glucagon secretion in the isolated pancreas of the rat is increased by arginine and not inhibited by glucose. This latter finding has been described also in the human newborn by Luyckx et al (10) using the intravenous glucose tolerance test. An increase in insulin and glucagon in the plasma of premature infants has been found after arginine in this research.…”
Section: Discussionsupporting
confidence: 61%
“…Edwards et al (4) have reported that during the first 3 days of life the glucagon secretion in the isolated pancreas of the rat is increased by arginine and not inhibited by glucose. This latter finding has been described also in the human newborn by Luyckx et al (10) using the intravenous glucose tolerance test. An increase in insulin and glucagon in the plasma of premature infants has been found after arginine in this research.…”
Section: Discussionsupporting
confidence: 61%
“…In addition, in species such as sheep and rabbit in which plasma glucose levels do not decrease at birth, an acute increase of plasma glucagon can nevertheless be observed [40,42]. On the other hand, direct evidence of the inability of glucose to reduce glucagon secretion in the newborn has been indicated by in vivo studies in the rat [59] and human [38,60]. The neonatal insensitivity to hyperglycemia has been pro posed to be due in part to low glucoseinduced insulin release of the neonatal pancreas [61].…”
Section: Effect Of Glucose On Glucagon Secretion In the Newbornmentioning
confidence: 89%
“…Glucagon concentration in the plasma of the fetus at term has been reported to be similar to that of maternal plasma in the rabbit [12], sheep [14,34,35], monkey [26], and human [32,36,37], Increased plasma glucagon concentrations compared to that of the adult have been observed in the rat fetus at term [24,32] and this concentration rises acutely during the early postnatal period in the human [32,38,39], sheep [40] and rat [41] , In these species, glucagon concentra tions values increase about threefold to a peak between 0 and 1-2 h postpartum and persists at values significantly greater than at birth during the perinatal period. In the rab bit, the increase of circulating glucagon which occurs after birth is more progressive [42] , Therefore, in all species studied, the plasma insulin/glucagon molar ratio is very high in the fetus at term, then decreases dra matically immediately after birth and re mains low during the first hours of extrauter ino life.…”
Section: Insulin and Glucagon In The Fetus At Term And The Newbornmentioning
confidence: 99%
“…However, both a decrease in glycemia and an increase in IRG have been reported in the human newborn (70,71). The secretory behavior of the human a-cell at birth may thus be relevant to normal extrauterine adaptation, and altered secretion may contribute to abnormal states of glucoregulation demonstrated in the infants of diabetic mothers.…”
Section: Methodsmentioning
confidence: 99%